BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1605665)

  • 1. [A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
    Inuyama Y; Miyake H; Horiuchi M; Hayasaki K; Komiyama S; Ota K
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):871-7. PubMed ID: 1605665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An early phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
    Inuyama Y; Miyake H; Horiuchi M; Hayasaki K; Komiyama S; Ota K
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):863-9. PubMed ID: 1605664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
    Noda K; Ikeda M; Yakushiji M; Nishimura H; Terashima Y; Sasaki H; Hata T; Kuramoto H; Tanaka K; Takahashi T
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):885-92. PubMed ID: 1605666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
    Taguchi T; Wakui A; Nabeya K; Kurihara M; Isono K; Kakegawa T; Ota K
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):483-8. PubMed ID: 1558398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
    Furuse K; Fukuoka M; Kurita Y; Ariyoshi Y; Niitani H; Yoneda S; Fujii M; Hasegawa K; Nishiwaki Y; Tamura M
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):879-84. PubMed ID: 1318698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for advanced breast cancer].
    Koyama H; Ogawa M; Kuraishi Y; Tominaga K; Yoshida M; Taguchi T
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1049-53. PubMed ID: 1626940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of carboplatin in head and neck cancer].
    Inuyama Y; Togawa K; Morita M; Takeoda S; Kaneko T; Takemiya S; Ono I; Nomura Y; Okuda M; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2131-8. PubMed ID: 3293536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
    Kato T; Nishimura H; Yakushiji M; Noda K; Terashima Y; Takeuchi S; Takamizawa H; Suzuki M; Arai M; Ota M
    Gan To Kagaku Ryoho; 1992 May; 19(5):695-701. PubMed ID: 1580643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].
    Ota K; Wakui A; Majima H; Niitani H; Inuyama Y; Ogawa M; Ariyoshi Y; Yoshida O; Taguchi T; Kimura I
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):855-61. PubMed ID: 1605663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A cooperative phase II study of cisplatin in patients with head and neck cancer].
    Inuyama Y; Takeda C
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):232-8. PubMed ID: 3004363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
    Sasaki Y; Amano T; Morita M; Shinkai T; Eguchi K; Tamura T; Ohe Y; Kojima A; Saijo N
    Cancer Res; 1991 Mar; 51(5):1472-7. PubMed ID: 1997185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A combination of low-dose carboplatin (CBDCA) and radiation therapy in head and neck cancer patients--response and hematologenic toxicity].
    Watanabe N; Kaneko T; Fujitani S; Umeyama M; Nomura Y; Zusho H; Yamada Y; Nanba G; Asahina N; Sugio Y; Okamoto Y; Daida T; Tokumaru T
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):101-6. PubMed ID: 9987505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II study of carboplatin in cervical carcinoma].
    Noda K; Kato T; Ikeda M; Akiya K; Yajima A; Ueda G; Nishiya I; Takamizawa H; Terashima Y; Tsutsui F
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3067-72. PubMed ID: 3056277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Late phase II study of S-1 in patients with advanced head and neck cancer].
    Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B;
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
    Horiuchi M; Miyake H; Ota K
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of a phase II study with the new cytostatic drug carboplatin in combination with 5-fluorouracil in the primary treatment of advanced squamous cell cancers of the head and neck].
    Volling P; Schröder M; Rauschning W; Achterrath W; Stennert E; Nagel G
    HNO; 1988 Nov; 36(11):452-5. PubMed ID: 3069815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
    Urade M; Yanagisawa T; Kishimoto H; Yoshioka W; Teranobu O; Shigeta Y; Komori T; Shimada K; Ohnishi M; Tanaka Y; Kamiya Y; Akazawa N; Oko T; Takahashi N; Adachi R; Tanigaki S; Hirata Y; Yakushiji N; Kitamura R; Hashikawa N;
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):789-95. PubMed ID: 11432346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin, an active drug in advanced head and neck cancer.
    de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
    Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.